Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Review of the Clinical, Radiological and Biochemical Characteristics and Genetic Causes of High Bone Mass Disorders.

Current drug targets - 1 Jan 2018

Chen Xiang, Yu Hongling, Yu Xijie

Abstract excerpt

BACKGROUND: High bone mass (HBM) disorders are a group of clinically and genetically heterogeneous bone diseases characterized by increased bone density on radiographs, due to progressive bone overgrowth or impaired bone resorption, or both. Some HBM cases are secondary to other diseases, such as chronic hepatitis C virus infection. Despite the great advance in gene diagnostic technology, the majority of HBM...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alkaline Phosphatase
Share to Bone Density
Share to Bone Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bone Resorption

Share to Osteoclasts

Share to Osteopetrosis

Share to Osteosclerosis

Share to Wnt Signaling Pathway

Source

Identifiers

PMID: 29359663
DOI: 10.2174/1389450119666180122161503

Genes

HBM

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Review of the Clinical, Radiological and Biochemical Characteristics and Genetic Causes of High Bone Mass Disorders.PMID 29359663Read ↗

Heritable sclerosing bone disorders: presentation and new molecular mechanisms.Semantic proximity Read ↗

Clinical description and genetic analysis of a novel familial skeletal dysplasia characterized by high bone mass and lucent bone lesions.Semantic proximity Read ↗

Genetic control of bone mass.Semantic proximity Read ↗

Clinical features, treatment, and follow-up of OPPG and high-bone-mass disorders: LRP5 is a key regulator of bone mass.Semantic proximity Read ↗

Taxonomy of rare genetic metabolic bone disorders.Semantic proximity Read ↗

Mutations in Known Monogenic High Bone Mass Loci Only Explain a Small Proportion of High Bone Mass Cases.Semantic proximity Read ↗

Paget’s disease: a review of the epidemiology, etiology, genetics, and treatmentSemantic proximity Read ↗

Skeletal dysplasias with increased bone density: evolution of molecular pathogenesis in the last century.Semantic proximity Read ↗

Biology and Treatment of Paget's Disease of Bone.Semantic proximity Read ↗

Congenital Metabolic Bone Disorders as a Cause of Bone Fragility.Semantic proximity Read ↗

Lessons from rare diseases of cartilage and bone.Semantic proximity Read ↗

The new bone biology: pathologic, molecular, and clinical correlates.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.